Comments on “Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study” —Efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus [Letter to the Editor]

Saved in:
Bibliographic Details
Published in:Endocrine Journal 2013, Vol.60(9), pp.1115-1115
Main Author: Kamoi, Kyuzi
Format: Article
Language:English
Subjects:
Antidiuretic Agents - administration & dosage
Deamino Arginine Vasopressin - administration & dosage
Diabetes Insipidus, Neurogenic - drug therapy
Female
Humans
Male
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2956-47d4a7e468dd439c81a75ad3e5e7c2151c853acba2399791a94ef62591a7c6c83
container_end_page 1115
container_issue 9
container_start_page 1115
container_title Endocrine Journal
container_volume 60
creator Kamoi, Kyuzi
description
doi_str_mv 10.1507/endocrj.EJ13-0276
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1438573817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1438573817</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2956-47d4a7e468dd439c81a75ad3e5e7c2151c853acba2399791a94ef62591a7c6c83</originalsourceid><addsrcrecordid>eNqVksGu1CAYhavReMerD-DGsHTTK5RSwJVmMl41k7jRlTENA39nmLSlAo3p7j6ES325-yRSZ2xiogs37U_7ncMhnCx7QvAVYZg_h9447Y9Xm3eE5rjg1d1sRWgp8pKV-F62wpKIXEgmL7KHIRwxppSV9EF2UVBR0QIXqzsv167roI8BuR7d3nzfNI3VSk9I9QYF1UCckGuQgdC5wUMItkfOq7adkLFpEWHvVbT9HkW1ayGi9H9IH35ZfrXxgHQakyDhagcRQiKCHawZwwuUDMd23rtBCnVptDMNHrkB-rxNgqRzAfJo47xNyhjiaKbbmx8p7Ld_hP17vj-OcAob_ict-rSFOGeLDsUDoI2x0fnPj7L7jWoDPD6_L7OPrzcf1m_y7fvrt-tX21wXklV5yU2pOJSVMKakUguiOFOGAgOuC8KIFowqvVMFlZJLomQJTVWwNHFdaUEvs2cn38G7LyOEWHc2aGhb1YMbQ01KKhingvCEkhOqvQvBQ1MP3nbKTzXB9Vyc-lycei5OPRcnaZ6e7cddB2ZR_G5KAq5PwDFEtYcFUD5dWguLZYVrOT8W64XQB-UTRn8CtMXnuw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1438573817</pqid></control><display><type>article</type><title>Comments on “Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study” —Efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus [Letter to the Editor]</title><source>J-STAGE</source><creator>Kamoi, Kyuzi</creator><creatorcontrib>Kamoi, Kyuzi</creatorcontrib><identifier>ISSN: 0918-8959</identifier><identifier>EISSN: 1348-4540</identifier><identifier>DOI: 10.1507/endocrj.EJ13-0276</identifier><identifier>PMID: 23863202</identifier><language>eng</language><publisher>Japan: The Japan Endocrine Society</publisher><subject>Antidiuretic Agents - administration &amp; dosage ; Deamino Arginine Vasopressin - administration &amp; dosage ; Diabetes Insipidus, Neurogenic - drug therapy ; Female ; Humans ; Male</subject><ispartof>Endocrine Journal, 2013, Vol.60(9), pp.1115-1115</ispartof><rights>The Japan Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2956-47d4a7e468dd439c81a75ad3e5e7c2151c853acba2399791a94ef62591a7c6c83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1882,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23863202$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kamoi, Kyuzi</creatorcontrib><title>Comments on “Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study” —Efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus [Letter to the Editor]</title><title>Endocrine Journal</title><addtitle>Endocr J</addtitle><subject>Antidiuretic Agents - administration &amp; dosage</subject><subject>Deamino Arginine Vasopressin - administration &amp; dosage</subject><subject>Diabetes Insipidus, Neurogenic - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><issn>0918-8959</issn><issn>1348-4540</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqVksGu1CAYhavReMerD-DGsHTTK5RSwJVmMl41k7jRlTENA39nmLSlAo3p7j6ES325-yRSZ2xiogs37U_7ncMhnCx7QvAVYZg_h9447Y9Xm3eE5rjg1d1sRWgp8pKV-F62wpKIXEgmL7KHIRwxppSV9EF2UVBR0QIXqzsv167roI8BuR7d3nzfNI3VSk9I9QYF1UCckGuQgdC5wUMItkfOq7adkLFpEWHvVbT9HkW1ayGi9H9IH35ZfrXxgHQakyDhagcRQiKCHawZwwuUDMd23rtBCnVptDMNHrkB-rxNgqRzAfJo47xNyhjiaKbbmx8p7Ld_hP17vj-OcAob_ict-rSFOGeLDsUDoI2x0fnPj7L7jWoDPD6_L7OPrzcf1m_y7fvrt-tX21wXklV5yU2pOJSVMKakUguiOFOGAgOuC8KIFowqvVMFlZJLomQJTVWwNHFdaUEvs2cn38G7LyOEWHc2aGhb1YMbQ01KKhingvCEkhOqvQvBQ1MP3nbKTzXB9Vyc-lycei5OPRcnaZ6e7cddB2ZR_G5KAq5PwDFEtYcFUD5dWguLZYVrOT8W64XQB-UTRn8CtMXnuw</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Kamoi, Kyuzi</creator><general>The Japan Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2013</creationdate><title>Comments on “Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study” —Efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus [Letter to the Editor]</title><author>Kamoi, Kyuzi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2956-47d4a7e468dd439c81a75ad3e5e7c2151c853acba2399791a94ef62591a7c6c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antidiuretic Agents - administration &amp; dosage</topic><topic>Deamino Arginine Vasopressin - administration &amp; dosage</topic><topic>Diabetes Insipidus, Neurogenic - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kamoi, Kyuzi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kamoi, Kyuzi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comments on “Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study” —Efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus [Letter to the Editor]</atitle><jtitle>Endocrine Journal</jtitle><addtitle>Endocr J</addtitle><date>2013</date><risdate>2013</risdate><volume>60</volume><issue>9</issue><spage>1115</spage><epage>1115</epage><pages>1115-1115</pages><issn>0918-8959</issn><eissn>1348-4540</eissn><cop>Japan</cop><pub>The Japan Endocrine Society</pub><pmid>23863202</pmid><doi>10.1507/endocrj.EJ13-0276</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-8959
ispartof Endocrine Journal, 2013, Vol.60(9), pp.1115-1115
issn 0918-8959
1348-4540
language eng
recordid cdi_proquest_miscellaneous_1438573817
source J-STAGE
subjects Antidiuretic Agents - administration & dosage
Deamino Arginine Vasopressin - administration & dosage
Diabetes Insipidus, Neurogenic - drug therapy
Female
Humans
Male
title Comments on “Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study” —Efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus [Letter to the Editor]
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T16%3A24%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comments%20on%20%E2%80%9CEfficacy%20and%20safety%20of%20desmopressin%20orally%20disintegrating%20tablet%20in%20patients%20with%20central%20diabetes%20insipidus:%20results%20of%20a%20multicenter%20open-label%20dose-titration%20study%E2%80%9D%20%E2%80%94Efficacy%20and%20safety%20of%20orally%20disintegrating%20desmopressin%20tablets%20in%20patients%20with%20central%20diabetes%20insipidus%20%5BLetter%20to%20the%20Editor%5D&rft.jtitle=Endocrine%20Journal&rft.au=Kamoi,%20Kyuzi&rft.date=2013&rft.volume=60&rft.issue=9&rft.spage=1115&rft.epage=1115&rft.pages=1115-1115&rft.issn=0918-8959&rft.eissn=1348-4540&rft_id=info:doi/10.1507/endocrj.EJ13-0276&rft_dat=%3Cproquest_cross%3E1438573817%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2956-47d4a7e468dd439c81a75ad3e5e7c2151c853acba2399791a94ef62591a7c6c83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1438573817&rft_id=info:pmid/23863202&rfr_iscdi=true